DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
about
A genome-wide camptothecin sensitivity screen identifies a mammalian MMS22L-NFKBIL2 complex required for genomic stabilityHistone H3 lysine 56 acetylation and the response to DNA replication fork damageInhibition of Topoisomerase (DNA) I (TOP1): DNA Damage Repair and Anticancer TherapyThe Impact of Hedgehog Signaling Pathway on DNA Repair Mechanisms in Human CancerMechanisms and regulation of mitotic recombination in Saccharomyces cerevisiaeDrugging topoisomerases: lessons and challengesMitochondrial DNA damage and its consequences for mitochondrial gene expressionProgrammed activation of cancer cell apoptosis: A tumor-targeted phototherapeutic topoisomerase I inhibitorAssessment of the topoisomerase I gene copy number as a predictive biomarker of objective response to irinotecan in metastatic colorectal cancer.Gli1 protein regulates the S-phase checkpoint in tumor cells via Bid protein, and its inhibition sensitizes to DNA topoisomerase 1 inhibitorsStructural and dynamical effects induced by the anticancer drug topotecan on the human topoisomerase I - DNA complexExploring DNA topoisomerase I ligand space in search of novel anticancer agentsSolvent dependency of the UV-Vis spectrum of indenoisoquinolines: role of keto-oxygens as polarity interaction probesReplacement of the human topoisomerase linker domain with the plasmodial counterpart renders the enzyme camptothecin resistantToward discovering new anti-cancer agents targeting topoisomerase IIα: a facile screening strategy adaptable to high throughput platformCFS-1686 causes cell cycle arrest at intra-S phase by interference of interaction of topoisomerase 1 with DNAGenome-wide mRNA and microRNA profiling of the NCI 60 cell-line screen and comparison of FdUMP[10] with fluorouracil, floxuridine, and topoisomerase 1 poisonsGenetically defined subsets of human pancreatic cancer show unique in vitro chemosensitivity.Single-Molecule Supercoil Relaxation Assay as a Screening Tool to Determine the Mechanism and Efficacy of Human Topoisomerase IB Inhibitors.RNA Polymerase II Regulates Topoisomerase 1 Activity to Favor Efficient Transcription.DOSY NMR and MALDI-TOF evidence of covalent binding the DNA duplex by trimethylammonium salts of topotecan upon near UV irradiation.Advantages of an optical nanosensor system for the mechanistic analysis of a novel topoisomerase I targeting drug: a case study.Global fitness profiling of fission yeast deletion strains by barcode sequencingDesign, synthesis, and biological evaluation of O-2-modified indenoisoquinolines as dual topoisomerase I-tyrosyl-DNA phosphodiesterase I inhibitors.The DNA relaxation activity and covalent complex accumulation of Mycobacterium tuberculosis topoisomerase I can be assayed in Escherichia coli: application for identification of potential FRET-dye labeling sites.A sandwiched microarray platform for benchtop cell-based high throughput screening.Structure-based design, synthesis, and biological studies of new anticancer norindenoisoquinoline topoisomerase I inhibitorsImmobilizing topoisomerase I on a surface plasmon resonance biosensor chip to screen for inhibitorsIdentification of novel PARP inhibitors using a cell-based TDP1 inhibitory assay in a quantitative high-throughput screening platform.Biochemical assays for the discovery of TDP1 inhibitorsPyrosequencing of the Camptotheca acuminata transcriptome reveals putative genes involved in camptothecin biosynthesis and transportH2AX Phosphorylation: Its Role in DNA Damage Response and Cancer Therapy.Repair-specific functions of replication protein A.A kinetic clutch governs religation by type IB topoisomerases and determines camptothecin sensitivity.Rottlerin potentiates camptothecin-induced cytotoxicity in human hormone refractory prostate cancers through increased formation and stabilization of topoisomerase I-DNA cleavage complexes in a PKCδ-independent pathway.NPRL-Z-1, as a new topoisomerase II poison, induces cell apoptosis and ROS generation in human renal carcinoma cells.Development and validation of an immunoassay for quantification of topoisomerase I in solid tumor tissuesThe geometry of DNA supercoils modulates the DNA cleavage activity of human topoisomerase ICharacterization of DNA topoisomerase-1 in Spodoptera exigua for toxicity evaluation of camptothecin and hydoxy-camptothecin.Protein kinase CK2 is a central regulator of topoisomerase I hyperphosphorylation and camptothecin sensitivity in cancer cell lines
P2860
Q24306107-A8B67205-0EF7-4DD3-898B-B207FA379275Q24612284-EE1D05ED-84C5-4550-AC0A-4723E6766833Q26796576-A1394562-5698-48F8-BBEA-035E5A86DFD9Q26801375-DAF42D85-C269-4458-8928-CC8B98AE0105Q26864428-647D793E-2D35-48C2-8E78-3C1E1B8A5BCEQ27000099-A36160A9-053A-4B44-981D-A0774C1617AAQ27001150-606A9B4E-DE85-449B-9DC9-FB3EAB1CD611Q27333941-367BCBF0-77F2-491A-A7A3-2B23F8388A67Q27852685-298F452E-2D48-4C84-8096-444D962102FCQ28248615-4EAE8925-A930-4613-82D0-D30E1D730417Q28474230-C08A9895-02C5-4F38-ACAA-A7626DDF1D57Q28477194-FA96DC5F-C7AE-4B14-B998-D9D0CD1F8A70Q28533825-256DF4F0-F4D7-4E90-B722-BE13277EA925Q28534477-43E066E8-1F44-4BC4-BE57-7377A2733A9FQ28538627-8D37582E-E012-423A-AD37-A2A5F8B62B33Q28542408-B3400173-D42A-4D2E-AA9D-79E4E44DF748Q28741878-CD042C96-509E-4C2A-8BF5-792C0669E3E9Q30528894-561EBA2B-34EE-4973-85DD-CCEF19D628C0Q30673594-323C22D1-A1DC-4404-AE70-AA65F3EC0EC2Q30740300-D81FFEB5-280E-4BCE-9896-C52D50AE46A6Q30960052-9BBCC8E1-1975-40C2-B9D6-9E5C63DC204AQ31155008-30E16492-8E7D-42AC-AE33-CF1864364D9FQ33600264-58BCCAF7-07D0-46AB-AA5C-9CDAB2F40377Q33662415-44864691-220B-402B-8B2B-894D795797E5Q33710021-B2B7EC80-E9BF-4560-8831-E491F0FA5075Q33724982-F99C67FB-E56B-44EA-80A8-6AB8AC662FF4Q33725863-7128B379-5D2C-49DD-85A0-9B5505A55E2DQ33968743-A367A54A-1D0C-4D40-B6C0-B4FD222B2BEDQ34017010-2EBC1497-20CA-445E-883E-51378A8E5AF8Q34021070-2A009F31-BBE7-4A7B-BD86-CB14B274FD0AQ34060787-4BBD5798-B05E-4FE2-BD9B-DF9BD4CE5584Q34089263-73672401-BF00-42CA-94DB-CBF756AC3C2AQ34104803-9F10AD80-6207-4588-8094-4E3B6363CC23Q34300595-FC52EA3E-4D02-487E-981B-A9C3FBE90554Q34401367-30631846-98D2-4DDE-B7C7-4D8186904545Q34459467-6DD0C43E-7AA3-4AE9-A12A-3C11A8379F11Q34531543-F5CCBB3D-7283-4299-A98F-5EED4F58A74FQ34559593-73308634-88D9-46C7-8CEC-CD0458D8A411Q34602383-62D4227A-5884-4980-B300-714202999EC1Q34615210-774F479D-B8DF-4D27-8754-85D4F141C4D2
P2860
DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
description
2009 nî lūn-bûn
@nan
2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
@ast
DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
@en
type
label
DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
@ast
DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
@en
prefLabel
DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
@ast
DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
@en
P2860
P3181
P356
P1433
P1476
DNA Topoisomerase I Inhibitors: Chemistry, Biology, and Interfacial Inhibition
@en
P2860
P304
P3181
P356
10.1021/CR900097C
P50
P577
2009-07-08T00:00:00Z